Physician profile
Robin E Caravallo
NPI 1851413892
$1,158.43
in general payments reported to CMS, 2019-2025
10 companies · $625 in 2025
The $625 reported for 2025 was more than what 80% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $128 · 2022: $124 · 2023: $110 · 2024: $171 · 2025: $625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $796.38 |
| Education | $109.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $260.20 | 2021-2024 | Opdivo |
| Pfizer INC. | $138.34 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $130.95 | 2025 | Enhertu |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2025 | |
| Seagen INC. | $124.10 | 2022 | |
| Pharmaessentia USA Corporation | $122.27 | 2025 | Besremi |
| Gilead Sciences, INC. | $121.85 | 2025 | |
| Incyte Corporation | $85.95 | 2023 | |
| Abbvie INC. | $25.97 | 2024 | |
| Karyopharm Therapeutics INC. | $23.80 | 2023 | Xpovio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Caravallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.